Cipla EU to form JV in USA
    Home » News » Cipla EU to form JV in USA
News

Cipla EU to form JV in USA

  • By IPP Bureau | January 07, 2024

Cipla (EU) Limited, wholly owned subsidiary of Cipla Limited in UK, has entered into a joint venture agreement with Kemwell Biopharma UK Limited and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The JV entity is being incorporated with an objective of commercialising novel cell therapy products in USA, Japan and EU region.

Upcoming E-conference

Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

 July 17, 2026
Register Now

Other Related stories

FDA advisory panel backs Moderna flu vaccine candidate for older adults
FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
View More

Interviews

India is b
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Cancer tre
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
We plan to
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
View More

Appointments

Pfizer CFO Dave Denton to exit
Pfizer CFO Dave Denton to exit
Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC
Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC
View More

Startup

Lumos Health opens applications for second cohort of HealthTech and MedTech startups
Lumos Health opens applications for second cohort of HealthTech and MedTech startups
Hoola Health raises $5 million to expand child-centric paediatric care
Hoola Health raises $5 million to expand child-centric paediatric care
HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
View More

Digitization

CENT expands to Delhi-NCR with new clinical prevention centre in Gurugram
CENT expands to Delhi-NCR with new clinical prevention centre in Gurugram
proRITHM named among top 4 AI-based healthcare technologies
proRITHM named among top 4 AI-based healthcare technologies
Life sciences firms move from AI pilots to scaled adoption, finds KPMG Global Tech Report 2026
Life sciences firms move from AI pilots to scaled adoption, finds KPMG Global Tech Report 2026
View More

Upcoming E-conference
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

FDA advisory panel backs Moderna flu vaccine candidate for older adults

FDA clears 131 drugs as global pharma approval momentum rebounds in 2025

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm
Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

Interviews
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Dr. Manjiri Bakre CEO and Founder, OncoStem Diagnostics
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
Akhil Ravi Chief Executive Officer, Aurigene Pharmaceutical Services Limited

Packaging
Coveris launches circular solution for stretch sleeves with ReCover
Coveris launches circular solution for stretch sleeves with ReCover
UFlex secures USFDA approval for recycled PE in food packaging
UFlex secures USFDA approval for recycled PE in food packaging
ALPLA opens new manufacturing plant in Thailand
ALPLA opens new manufacturing plant in Thailand